TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.540
-0.060 (-3.75%)
At close: Sep 10, 2025, 4:00 PM
1.570
+0.030 (1.95%)
After-hours: Sep 10, 2025, 4:00 PM EDT
TELA Bio Employees
TELA Bio had 209 employees as of December 31, 2024. The number of employees decreased by 18 or -7.93% compared to the previous year.
Employees
209
Change (1Y)
-18
Growth (1Y)
-7.93%
Revenue / Employee
$360,397
Profits / Employee
-$195,057
Market Cap
61.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209 | -18 | -7.93% |
| Dec 31, 2023 | 227 | 54 | 31.21% |
| Dec 31, 2022 | 173 | 50 | 40.65% |
| Dec 31, 2021 | 123 | 15 | 13.89% |
| Dec 31, 2020 | 108 | 19 | 21.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TELA News
- 4 weeks ago - TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 7 weeks ago - TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - GlobeNewsWire
- 3 months ago - TELA Bio Appoints Jeffrey Blizard as President - GlobeNewsWire